Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  18,433 results for ""Tumor Necrosis Factor Inhibitors""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.

  • Authors : Latini A; Department of Biomedicine and Prevention, Genetics Section, University of Rome 'Tor Vergata', 00133 Rome, Italy.; De Benedittis G

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/genetics

  • Source: Genes [Genes (Basel)] 2024 Feb 12; Vol. 15 (2). Date of Electronic Publication: 2024 Feb 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis.

  • Authors : Tian X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.; Li M

Subjects: Takayasu Arteritis*/Takayasu Arteritis*/Takayasu Arteritis*/drug therapy ; Tumor Necrosis Factor Inhibitors*/Tumor Necrosis Factor Inhibitors*/Tumor Necrosis Factor Inhibitors*/therapeutic use; Humans

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Aug; Vol. 75 (8), pp. 1415-1423. Date of Electronic Publication: 2023 Jun 08.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Comparative efficacy of secukinumab versus tumor necrosis factor inhibitors for Takayasu arteritis: comment on the article by Tian et al.

  • Authors : Singh K; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.; Misra DP

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Takayasu Arteritis*/Takayasu Arteritis*/Takayasu Arteritis*/drug therapy ; Tumor Necrosis Factor Inhibitors*/Tumor Necrosis Factor Inhibitors*/Tumor Necrosis Factor Inhibitors*/therapeutic use

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Oct; Vol. 75 (10), pp. 1871. Date of Electronic Publication: 2023 Jul 31.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.

  • Authors : Ørnbjerg LM; L.M. Ørnbjerg, MD, PhD, K. Rugbjerg, MSc, PhD, S. Georgiadis, MSc, PhD, S.H. Rasmussen, MSc, PhD, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark; .

Subjects: Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/diagnosis ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: The Journal of rheumatology [J Rheumatol] 2024 Apr 01; Vol. 51 (4), pp. 378-389. Date of Electronic Publication: 2024 Apr 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.

Subjects: Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Spondylarthritis*/Spondylarthritis*/Spondylarthritis*/drug therapy

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Apr; Vol. 76 (4), pp. 587-598. Date of Electronic Publication: 2024 Feb 25.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.

  • Authors : Eviatar T; T. Eviatar, MD, V. Furer, MD, A. Polachek, MD, O. Elalouf, MD, D. Levartovsky, MD, I. Kaufman, MD, A. Broyde, MD, S. Pel, MPH, D. Paran, MD, O. Elkayam, MD, Rheumatology Department, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; .

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Spondylarthritis*/Spondylarthritis*/Spondylarthritis*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy COVID-19 breakthrough infections

  • Source: The Journal of rheumatology [J Rheumatol] 2024 Apr 01; Vol. 51 (4), pp. 415-422. Date of Electronic Publication: 2024 Apr 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors.

  • Authors : Sobral D; Applied Molecular Biosciences Unit, Life Sciences Department, Sciences and Technology School, NOVA University of Lisbon, 2829-516 Caparica, Portugal.; Fernandes AF

Subjects: Spondylitis, Ankylosing* ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Axial Spondyloarthritis*

  • Source: Biomolecules [Biomolecules] 2024 Mar 21; Vol. 14 (3). Date of Electronic Publication: 2024 Mar 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

Read More Add to Saved list
×
Academic Journal

Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.

  • Authors : Hajizadeh N; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), Iran University of Medical Sciences, Tehran, Iran.

Subjects: Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/adverse effects; Humans ; Adalimumab/Adalimumab/Adalimumab/therapeutic use

  • Source: PloS one [PLoS One] 2024 Feb 09; Vol. 19 (2), pp. e0293433. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

Screening, prophylaxis, and challenges: Tumor necrosis factor inhibitors and latent tuberculosis infection nexus in rheumatology.

  • Authors : Su K; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin Province, China.; Department of Clinical Epidemiology, the First Hospital of Jilin University, Changchun, Jilin Province, China.

Subjects: Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/diagnosis ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/drug therapy ; Rheumatology*

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Jan; Vol. 27 (1), pp. e14996. Date of Electronic Publication: 2023 Dec 07.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases.

  • Authors : Ward D; Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark. Electronic address: .; Nyboe Andersen N

Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/drug therapy ; Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/chemically induced ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/epidemiology

  • Source: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Jan; Vol. 22 (1), pp. Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  18,433 results for ""Tumor Necrosis Factor Inhibitors""